167 related articles for article (PubMed ID: 18682921)
1. Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.
Vorobyov V; Sengpiel F
Exp Brain Res; 2008 Nov; 191(3):277-87. PubMed ID: 18682921
[TBL] [Abstract][Full Text] [Related]
2. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease.
Vorobyov VV; Schibaev NV; Morelli M; Carta AR
Brain Res; 2003 May; 972(1-2):177-85. PubMed ID: 12711091
[TBL] [Abstract][Full Text] [Related]
3. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
Pollack AE; Strauss JB
Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
[TBL] [Abstract][Full Text] [Related]
4. NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats.
Pollack AE; Haisley EC
Brain Res; 2001 Apr; 897(1-2):213-6. PubMed ID: 11282380
[TBL] [Abstract][Full Text] [Related]
5. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
[TBL] [Abstract][Full Text] [Related]
6. Cortical and Striatal Electroencephalograms and Apomorphine Effects in the FUS Mouse Model of Amyotrophic Lateral Sclerosis.
Vorobyov V; Deev A; Sengpiel F; Nebogatikov V; Ustyugov AA
J Alzheimers Dis; 2021; 81(4):1429-1443. PubMed ID: 33935079
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
8. Blockade of NMDA receptors by MK-801 reverses the changes in striatal glutamate immunolabeling in 6-OHDA-lesioned rats.
Robinson S; Krentz L; Moore C; Meshul CK
Synapse; 2001 Oct; 42(1):54-61. PubMed ID: 11668591
[TBL] [Abstract][Full Text] [Related]
9. Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response.
Gancher S; Mayer A
Brain Res; 1995 Jun; 682(1-2):63-8. PubMed ID: 7552328
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
11. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
Kerkerian L; Nieoullon A
Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320
[TBL] [Abstract][Full Text] [Related]
12. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
Rodríguez-Puertas R; Herrera-Marschitz M; Koistinaho J; Hökfelt T
Neuroscience; 1999 Mar; 89(3):781-97. PubMed ID: 10199613
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
[TBL] [Abstract][Full Text] [Related]
17. Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons.
Frau L; Morelli M; Simola N
Exp Neurol; 2013 Sep; 247():663-72. PubMed ID: 23499830
[TBL] [Abstract][Full Text] [Related]
18. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat.
Sharott A; Magill PJ; Harnack D; Kupsch A; Meissner W; Brown P
Eur J Neurosci; 2005 Mar; 21(5):1413-22. PubMed ID: 15813951
[TBL] [Abstract][Full Text] [Related]
19. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors.
Liste I; Rozas G; Guerra MJ; Labandeira-Garcia JL
Brain Res; 1995 Nov; 700(1-2):1-12. PubMed ID: 8624698
[TBL] [Abstract][Full Text] [Related]
20. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
